Get the Stockscreener App
24.17
0.60%
0.11
Tango Therapeutics Inc stock is traded at $24.17, with a volume of 609.38K.
It is up +0.60% in the last 24 hours and up +39.91% over the past month.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
See More
Previous Close:
$24.06
Open:
$23.94
24h Volume:
609.38K
Relative Volume:
0.18
Market Cap:
$3.46B
Revenue:
$62.38M
Net Income/Loss:
$-101.59M
P/E Ratio:
-27.96
EPS:
-0.8644
Net Cash Flow:
$-139.93M
1W Performance:
+20.66%
1M Performance:
+39.91%
6M Performance:
+154.25%
1Y Performance:
+1,660%
1-Day Range:
$23.93
$25.13
1-Week Range:
$19.68
$25.13
52-Week Range:
$1.03
$25.13
Tango Therapeutics Inc Stock (TNGX) Company Profile
Name
Tango Therapeutics Inc
Sector
Industry
Phone
(857) 320-4900
Address
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
24.25 | 3.43B | 62.38M | -101.59M | -139.93M | -0.8644 |
VRTX
Vertex Pharmaceuticals Inc
|
440.28 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
751.02 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
845.09 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.58 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.66 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-26 | Initiated | Canaccord Genuity | Buy |
| Feb-23-26 | Initiated | Mizuho | Outperform |
| Nov-18-25 | Initiated | Wolfe Research | Peer Perform |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-17-24 | Initiated | Jefferies | Buy |
| Apr-04-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-24 | Initiated | Piper Sandler | Overweight |
| Dec-08-23 | Initiated | B. Riley Securities | Buy |
| Oct-20-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-20-21 | Initiated | SVB Leerink | Outperform |
View All
Tango Therapeutics Inc Stock (TNGX) Latest News
Tango Therapeutics Inc stock hits all-time high of 22.21 USD - Investing.com India
Leerink raises Tango Therapeutics stock price target on PDAC data By Investing.com - Investing.com South Africa
Update Report: Is Tango Therapeutics Inc in a long term uptrendCEO Change & Smart Money Movement Tracker - baoquankhu1.vn
Leerink raises Tango Therapeutics stock price target on PDAC data - Investing.com
Performance Recap: Will Tango Therapeutics Inc benefit from rising consumer demand2026 Macro Moves & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Momentum Shift: Will Tango Therapeutics Inc stock go up in YEARWeekly Profit Recap & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Moving Averages: Will Tango Therapeutics Inc benefit from rising consumer demandM&A Rumor & Weekly High Momentum Picks - baoquankhu1.vn
Tango Therapeutics is the best performing healthcare stock in March - MSN
TNGX Should I Buy - Intellectia AI
Stifel and Jefferies raise targets on Tango Therapeutics (TNGX) - MSN
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets - The Globe and Mail
Symbol lookup from Yahoo Finance - Yahoo Finance Australia
Tango Therapeutics (TNGX) sees cautious analyst optimism following earnings - MSN
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) - Insider Monkey
Tango Therapeutics (NASDAQ:TNGX) Trading Down 4.3%Here's What Happened - marketbeat.com
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
10 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey
Does Tango Therapeutics’ (TNGX) New ATM Plan Reframe Its Long‑Term Funding and Trial Risk Balance? - Sahm
Canaccord Genuity initiates coverage of Tango Therapeutics (TNGX) with buy recommendation - MSN
Tango Therapeutics stock hits all-time high at 21.84 USD By Investing.com - Investing.com Australia
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells 27,000 Shares of Stock - MarketBeat
Tango a new Buy at Canaccord Genuity on 2026 catalysts - MSN
Tango Therapeutics president sells $572k in shares By Investing.com - Investing.com Canada
Tango Therapeutics (NASDAQ: TNGX) president sells 27,000 shares - Stock Titan
Tango stock is a new Buy at Canaccord Genuity (TNGX:NASDAQ) - Seeking Alpha
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month HighHere's Why - MarketBeat
Tango Therapeutics stock hits all-time high at 21.84 USD - Investing.com
Canaccord Genuity Group Begins Coverage on Tango Therapeutics (NASDAQ:TNGX) - MarketBeat
CCORF Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $30 - Moomoo
Tudor Investment Corp ET AL Takes $450,000 Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
Is Tango Therapeutics Inc a strong candidate for buy and hold2026 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Decliners Report: Can Tango Therapeutics Inc be recession proof2026 Fed Impact & Free Reliable Trade Execution Plans - baoquankhu1.vn
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
TNGX Stock Price, Quote & Chart | TANGO THERAPEUTICS INC (NASDAQ:TNGX) - ChartMill
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge - AOL.com
Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA) - Seeking Alpha
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum - Yahoo Finance
Geopolitics Watch: Can Tango Therapeutics Inc ride the EV waveTrade Performance Summary & Community Verified Trade Alerts - baoquankhu1.vn
Adam Crystal Sells 12,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
Tango Therapeutics Inc Stock (TNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.76%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):